Cargando…
Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma
Herpes simplex virus-1 (HSV-1) infection is the most common cause of encephalitis. This virus commonly lays dormant in neural ganglia, specifically the trigeminal ganglia, following retrograde axonal transport from the site of infection. States of immunosuppression can activate the virus to cause ac...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539624/ https://www.ncbi.nlm.nih.gov/pubmed/36212758 http://dx.doi.org/10.1016/j.radcr.2022.09.018 |
_version_ | 1784803529534210048 |
---|---|
author | Waack, Andrew Jaggernauth, Sarah Iordanou, James Vattipally, Venkatramana |
author_facet | Waack, Andrew Jaggernauth, Sarah Iordanou, James Vattipally, Venkatramana |
author_sort | Waack, Andrew |
collection | PubMed |
description | Herpes simplex virus-1 (HSV-1) infection is the most common cause of encephalitis. This virus commonly lays dormant in neural ganglia, specifically the trigeminal ganglia, following retrograde axonal transport from the site of infection. States of immunosuppression can activate the virus to cause active infection. There are several causes of immunosuppression that can cause viral reactivation. Sporadic case reports have demonstrated HSV-1 encephalitis following brain radiotherapy, although no clear relationship between this treatment and HSV-1 encephalitis has been elucidated. HSV1 encephalitis that arises during immunocompromized states has an atypical presentation for encephalitis, potentially obfuscating the diagnosis and delaying subsequent treatment. The main diagnostic criteria, including CSF analysis, brain imaging, and clinical presentation, all commonly present atypically during states of immunosuppression. For these reasons, it is imperative for physicians to be aware of this rare sequelae in appropriate populations, such as patients undergoing brain radiotherapy. We present a case of an atypical presentation of HSV-1 encephalitis in a patient who recently completed radiotherapy for brain metastases secondary to renal cell carcinoma. |
format | Online Article Text |
id | pubmed-9539624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95396242022-10-08 Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma Waack, Andrew Jaggernauth, Sarah Iordanou, James Vattipally, Venkatramana Radiol Case Rep Case Report Herpes simplex virus-1 (HSV-1) infection is the most common cause of encephalitis. This virus commonly lays dormant in neural ganglia, specifically the trigeminal ganglia, following retrograde axonal transport from the site of infection. States of immunosuppression can activate the virus to cause active infection. There are several causes of immunosuppression that can cause viral reactivation. Sporadic case reports have demonstrated HSV-1 encephalitis following brain radiotherapy, although no clear relationship between this treatment and HSV-1 encephalitis has been elucidated. HSV1 encephalitis that arises during immunocompromized states has an atypical presentation for encephalitis, potentially obfuscating the diagnosis and delaying subsequent treatment. The main diagnostic criteria, including CSF analysis, brain imaging, and clinical presentation, all commonly present atypically during states of immunosuppression. For these reasons, it is imperative for physicians to be aware of this rare sequelae in appropriate populations, such as patients undergoing brain radiotherapy. We present a case of an atypical presentation of HSV-1 encephalitis in a patient who recently completed radiotherapy for brain metastases secondary to renal cell carcinoma. Elsevier 2022-10-04 /pmc/articles/PMC9539624/ /pubmed/36212758 http://dx.doi.org/10.1016/j.radcr.2022.09.018 Text en © 2022 The Authors. Published by Elsevier Inc. on behalf of University of Washington. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Waack, Andrew Jaggernauth, Sarah Iordanou, James Vattipally, Venkatramana Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma |
title | Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma |
title_full | Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma |
title_fullStr | Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma |
title_full_unstemmed | Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma |
title_short | Herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma |
title_sort | herpes simplex virus-1 encephalitis secondary to whole brain radiation therapy for metastatic renal cell carcinoma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9539624/ https://www.ncbi.nlm.nih.gov/pubmed/36212758 http://dx.doi.org/10.1016/j.radcr.2022.09.018 |
work_keys_str_mv | AT waackandrew herpessimplexvirus1encephalitissecondarytowholebrainradiationtherapyformetastaticrenalcellcarcinoma AT jaggernauthsarah herpessimplexvirus1encephalitissecondarytowholebrainradiationtherapyformetastaticrenalcellcarcinoma AT iordanoujames herpessimplexvirus1encephalitissecondarytowholebrainradiationtherapyformetastaticrenalcellcarcinoma AT vattipallyvenkatramana herpessimplexvirus1encephalitissecondarytowholebrainradiationtherapyformetastaticrenalcellcarcinoma |